VISUAL AND MORPHOLOGIC OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR DIABETIC MACULAR EDEMA BASED ON OPTICAL COHERENCE TOMOGRAPHY PATTERNS

Purpose: To evaluate the visual and morphologic outcomes of intravitreal ranibizumab (IVR) in eyes with diabetic macular edema (DME) based on the morphologic pattern on optical coherence tomography. Methods: A prospective and consecutive series of 55 eyes with DME was classified according to OCT features: diffuse retinal thickening (DRT), cystoid macular edema (CME), and serous retinal detachment (SRD). Patients received three consecutive monthly injections of IVR and as needed thereafter. The primary outcome was the number of treatments undertaken by DME type over 12 months. Best-corrected visual acuity, retinal thickness, and microstructural changes were also evaluated. Results: The eyes were classified as DRT (n = 23), CME (16), or SRD (16). The mean number of injections over 12 months was significantly different among the groups: DRT (3.69), CME (5.33), and SRD (5.09; P = 0.028). Best-corrected visual acuity of SRD (20/60) was significantly worse than that of the other types (DRT = 20/38; CME = 20/43; P = 0.015) after 12 months. Conclusion: Vision gains and retinal anatomy improvement were maintained in all three types during the first year of IVR administration. Especially, DRT maintained a good response to ranibizumab in a fewer number of injections. Disruption of the photoreceptor integrity at the baseline was correlated with poorer visual outcome and occurred more frequently in SRD.

[1]  A J BEDELL,et al.  Macular Edema , 2018, Klinische Monatsblätter für Augenheilkunde.

[2]  Michael F. Marmor,et al.  Mechanisms of fluid accumulation in retinal edema , 2004, Documenta Ophthalmologica.

[3]  L. Aiello,et al.  Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. , 1998, Ophthalmic research.

[4]  T. Nakazawa,et al.  VISUAL OUTCOME AFTER INTRAVITREAL TRIAMCINOLONE ACETONIDE DEPENDS ON OPTICAL COHERENCE TOMOGRAPHIC PATTERNS IN PATIENTS WITH DIFFUSE DIABETIC MACULAR EDEMA , 2011, Retina.

[5]  A. Loewenstein,et al.  General Pathophysiology of Macular Edema , 2011, European journal of ophthalmology.

[6]  Peter Wiedemann,et al.  Pathomechanisms of Cystoid Macular Edema , 2004, Ophthalmic Research.

[7]  S. Kishi,et al.  Patterns of diabetic macular edema with optical coherence tomography. , 1999, American journal of ophthalmology.

[8]  Seung-Young Yu,et al.  Effect of Intravitreal Bevacizumab Based on Optical Coherence Tomography Patterns of Diabetic Macular Edema , 2011, Ophthalmologica.

[9]  B. S. Fine,et al.  Pathology of human cystoid macular edema. , 1984, Survey of ophthalmology.

[10]  S. Sadda,et al.  Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN•OCT consensus. , 2014, Ophthalmology.

[11]  T. Nakazawa,et al.  VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB DEPENDS ON THE OPTICAL COHERENCE TOMOGRAPHIC PATTERNS OF PATIENTS WITH DIFFUSE DIABETIC MACULAR EDEMA , 2013, Retina.

[12]  N. Yoshimura,et al.  Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy. , 2011, American journal of ophthalmology.

[13]  Nagahisa Yoshimura,et al.  Optical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edema. , 2012, Investigative ophthalmology & visual science.

[14]  Chien-Hsiung Lai,et al.  Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[15]  Hyewon Chung,et al.  Association between photoreceptor integrity and visual outcome in diabetic macular edema , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[17]  S. A. Meyer,et al.  RELATIONSHIP BETWEEN PHOTORECEPTOR OUTER SEGMENT LENGTH AND VISUAL ACUITY IN DIABETIC MACULAR EDEMA , 2009, Retina.

[18]  Don-Il Ham,et al.  The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. , 2004, American journal of ophthalmology.

[19]  P Edwards Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema , 2010 .

[20]  Francesco Bandello,et al.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. , 2011, Ophthalmology.

[21]  Nagahisa Yoshimura,et al.  Foveal cystoid spaces are associated with enlarged foveal avascular zone and microaneurysms in diabetic macular edema. , 2011, Ophthalmology.

[22]  L. Aiello,et al.  Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. , 2012, Ophthalmology.